Jon LeCroy joined MKM Partners in June 2011 as an analyst covering the biotechnology/specialty pharmaceuticals sector. LeCroy previously covered the same sector at Hapoalim Securities USA, Natixis Bleichroeder and Goldman Sachs. He ranked #5 in this year's Wall Street Journal "Best on the Street" poll in biotechnology. He holds a Masters in Business Administration from Boston University's Graduate School of Management, an M.D. from University of South Florida College of Medicine and a Bachelor of Science in biology from Wake Forest University.